Records containing: Male Hypogonadism
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2026-03-30Clinical Evaluation of Subcutaneous Testosterone Implants in Men With Symptomatic Hypogonadism
-
CLINICAL_TRIALS study record update · 2026-03-20MORPHOMETRIC, FUNCTIONAL AND LIFESTYLE PREDICTORS OF TESTOSTERONE DECLINE IN MIDDLE-AGED MEN: A POPULATION-BASED CROSS-SECTIONAL STUDY
-
CLINICAL_TRIALS study record update · 2025-03-06Muscle Strength and -Mass After Bariatric Surgery - a Possible Effect of Testosterone Replacement Therapy? Randomized, Placebo-controlled and Double-blinded Study
-
CLINICAL_TRIALS study record update · 2024-02-28Testosterone Undecanoate Replacement Therapy in Boys With Pubertal Delay or Confirmed Hypogonadism
-
CLINICAL_TRIALS study record update · 2023-04-20Relationship of the Gut and Genitourinary Tract Microenvironment and Male Fertility
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2021-03-02D-chiroinositol Administration for Testosterone Level Improvement in Hypogonadal Males
-
CLINICAL_TRIALS study record update · 2020-12-11Pharmacokinetic Study to Determine Time to Steady-state of an Oral Testosterone Undecanoate Formulation in Hypogonadal Men.
-
CLINICAL_TRIALS study record update · 2020-12-02Phase II Study of the Effect of Food With Various Levels of Fat on the Pharmacokinetics of an Oral Testosterone Undecanoate Formulation in Hypogonadal Men
-
CLINICAL_TRIALS study record update · 2019-11-26A Phase 1, Randomised, Open-label, 2-cohort, Cross-over Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of a Native Oral Testosterone Formulation (DITEST) in the Fed and Fasted State and Compared to Testosterone Undecanoate in Adult Men With Primary or Secondary Hypogonadism
-
CLINICAL_TRIALS study record update · 2018-10-30Open-Label Study of Oral Testosterone Undecanoate (TU) in Hypogonadal Men
-
CLINICAL_TRIALS study record update · 2018-08-14Phase 3, Active-Controlled, Safety and Efficacy Trial of Oral Testosterone Undecanoate (TU) in Hypogonadal Men
-
CLINICAL_TRIALS study record update · 2018-06-13A 90-Day, Randomized, Dose-Ranging Study, Including Potential Dose Titration, Evaluating the Efficacy and Safety of Intranasal TBS-1 in the Treatment of Male Hypogonadism With Sequential Safety Extension Periods of 90 and 180 Days
-
CLINICAL_TRIALS study record update · 2017-10-23Phase 3, Active-Controlled, Safety and Efficacy Trial of Oral Testosterone Undecanoate (TU, LPCN 1021) in Hypogonadal Men
-
CLINICAL_TRIALS study record update · 2017-09-21Phase III, Open-label Study of the Safety and Efficacy of Oral Testosterone Undecanoate (TU)in Hypogonadal Men
-
CLINICAL_TRIALS study record update · 2016-10-18Autonomic Manifestations of Testosterone Deficiency in Men
-
CLINICAL_TRIALS study record update · 2016-08-24Registry of Hypogonadism in Men
-
CLINICAL_TRIALS study record update · 2014-07-315-Alpha Reductase and Anabolic Effects of Testosterone
-
CLINICAL_TRIALS study record update · 2013-07-22Assessment of Time to Eugonadal Testosterone Range After Initial Fortesta (Testosterone) Gel 2% Application, Time to Steady State After Initiation of Fortesta, And Gel Drying Time After Fortesta Application